-
EP4281104
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4281104
| EP4281104 - TUMOR-INFILTRATING LYMPHOCYTES WITH MEMBRANE BOUND INTERLEUKIN 15 AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 27.10.2023 Database last updated on 24.07.2024 | |
| Former | The international publication has been made Status updated on 29.07.2022 | ||
| Former | unknown Status updated on 16.02.2022 | Most recent event Tooltip | 22.03.2024 | Change: Validation states | published on 24.04.2024 [2024/17] | 22.03.2024 | Change - extension states | published on 24.04.2024 [2024/17] | Applicant(s) | For all designated states Obsidian Therapeutics, Inc. 1030 Massachusetts Avenue, Suite 400 Cambridge, MA 02138 / US | [2023/48] | Inventor(s) | 01 /
BURGA, Rachel Cambridge, Massachusetts 02138 / US | 02 /
KHATTAR, Mithun Cambridge, Massachusetts 02138 / US | 03 /
OLS, Michelle Cambridge, Massachusetts 02138 / US | 04 /
TCHAICHA, Jeremy Hatem Cambridge, Massachusetts 02138 / US | 05 /
SUBRAMANIAN, Shyamsundar Cambridge, Pennsylvania 02138 / US | 06 /
PEDRO, Kyle Cambridge, Massachusetts 02138 / US | 07 /
STORER, James Alexander Cambridge, Massachusetts 02138 / US | 08 /
TER MEULEN, Jan Cambridge, Massachusetts 02138 / US | [2023/48] | Representative(s) | Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | [N/P] |
| Former [2023/48] | Sagittarius IP Marlow International Parkway Marlow, SL7 1YL / GB | Application number, filing date | 22703258.8 | 18.01.2022 | [2023/48] | WO2022US70227 | Priority number, date | US202163139305P | 19.01.2021 Original published format: US 202163139305 P | US202163153367P | 24.02.2021 Original published format: US 202163153367 P | US202163226114P | 27.07.2021 Original published format: US 202163226114 P | US202163244166P | 14.09.2021 Original published format: US 202163244166 P | [2023/48] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022159939 | Date: | 28.07.2022 | Language: | EN | [2022/30] | Type: | A1 Application with search report | No.: | EP4281104 | Date: | 29.11.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 28.07.2022 takes the place of the publication of the European patent application. | [2023/48] | Search report(s) | International search report - published on: | EP | 28.07.2022 | Classification | IPC: | A61K39/00, A61P35/00, C12N5/0783, C07K14/54, C12N15/867 | [2023/48] | CPC: |
A61P35/00 (EP,KR,US);
A61K39/4611 (EP,KR,US);
A61K35/17 (US);
A61K39/4632 (US);
A61K39/4635 (EP,KR);
A61K39/4644 (US);
A61K39/46444 (US);
A61K39/464491 (EP,KR);
A61K39/464492 (EP,KR);
C07K14/5443 (EP,US);
C12N15/86 (EP,US);
C12N5/0636 (EP,KR,US);
C12N5/0638 (EP,KR);
A61K2039/5156 (US);
A61K2039/55527 (EP);
A61K2039/876 (EP);
A61K2239/31 (EP,KR);
A61K2239/38 (EP,KR);
A61K2239/57 (EP,KR);
C07K2319/03 (EP);
C12N2501/2315 (EP,KR);
C12N2501/2321 (EP,KR,US);
C12N2501/599 (US);
C12N2502/30 (EP,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/48] | Title | German: | TUMORINFILTRIERENDE LYMPHOZYTEN MIT MEMBRANGEBUNDENEM INTERLEUKIN 15 UND VERWENDUNGEN DAVON | [2023/48] | English: | TUMOR-INFILTRATING LYMPHOCYTES WITH MEMBRANE BOUND INTERLEUKIN 15 AND USES THEREOF | [2023/48] | French: | LYMPHOCYTES INFILTRANT LES TUMEURS AVEC INTERLEUKINE 15 LIÉE À LA MEMBRANE ET LEURS UTILISATIONS | [2023/48] | Entry into regional phase | 02.08.2023 | National basic fee paid | 02.08.2023 | Designation fee(s) paid | 02.08.2023 | Examination fee paid | Examination procedure | 02.08.2023 | Examination requested [2023/48] | 02.08.2023 | Date on which the examining division has become responsible | 29.02.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 14.12.2023 | Renewal fee patent year 03 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2019236577 (INTREXON CORP [US]); | [XP]WO2021050789 (OBSIDIAN THERAPEUTICS INC [US]); | by applicant | US8173792 | US8530636 | US9487787 | US2017114346 | WO2017156238 | WO2017181119 | WO2018161000 | US10137180 | WO2018231759 | WO2018237323 | US2019192691 | US2019300864 | WO2019241315 | US2020101142 | US2020172879 | US2021069248 | US19350172516 | WO2018US37005 | WO2019US36654 | WO2019US57698 | WO2020US21596 |